Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
9%
Ph not_applicable
10
91%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
1(9.1%)
N/ANon-phased studies
10(90.9%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

11

all time

Status Distribution
Completed(7)
Terminated(1)
Other(3)

Detailed Status

Completed7
unknown3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
0
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 11 (9.1%)
N/A10 (90.9%)

Trials by Status

unknown327%
withdrawn19%
completed764%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
PROCEDURE
Total Trials
11